Cargando…
Pharmacist and physician insight of vancomycin therapeutic drug-monitoring changes
The updated vancomycin guideline for treatment of serious methicillin-resistant Staphylococcus aureus infections prompted institutions to convert from trough to area-under-the-curve monitoring. The physician perception of the transition, coupled with that of pharmacists, was measured by pre- and pos...
Autores principales: | Gregory, Eric R., Stun, Lucy, Mason, Matt J., Wilson, Nicole M., Hammoud, Kassem A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9726509/ https://www.ncbi.nlm.nih.gov/pubmed/36483332 http://dx.doi.org/10.1017/ash.2022.282 |
Ejemplares similares
-
Vancomycin Prescribing Practices and Therapeutic Drug Monitoring for Critically Ill Neonatal and Pediatric Patients: A Survey of Physicians and Pharmacists in Hong Kong
por: Chow, Twinny Cheuk Hin, et al.
Publicado: (2020) -
Pharmacist-directed vancomycin therapeutic drug monitoring in pediatric patients: a collaborative-practice model
por: Hussain, Kashif, et al.
Publicado: (2021) -
Methicillin-resistant Staphylococcus aureus bacteremia with elevated vancomycin minimum inhibitory concentrations
por: Mills, Alexandra G., et al.
Publicado: (2023) -
182. Missed Opportunities to Discontinue Unnecessary Vancomycin During Pharmacist Therapeutic Monitoring
por: Medler, Corey J, et al.
Publicado: (2020) -
Audit of therapeutic drug monitoring of dosing of vancomycin on an intensive care unit
por: Mason, P, et al.
Publicado: (2002)